Development and pilot investigation of behavioral activation for negative symptoms

Hilary Mairs, Karina Lovell, Malcolm Campbell, Philip Keeley

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment.

Original languageEnglish
Pages (from-to)486-506
Number of pages21
JournalBehavior Modification
Volume35
Issue number5
DOIs
Publication statusPublished - 1 Sep 2011
Externally publishedYes

Fingerprint

Psychotic Disorders
Depression
Activation
Psychosis

Cite this

Mairs, Hilary ; Lovell, Karina ; Campbell, Malcolm ; Keeley, Philip. / Development and pilot investigation of behavioral activation for negative symptoms. In: Behavior Modification. 2011 ; Vol. 35, No. 5. pp. 486-506.
@article{ab10fdbcea2b4dc394b6e6506330addf,
title = "Development and pilot investigation of behavioral activation for negative symptoms",
abstract = "Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment.",
keywords = "negative symptoms, psychosis, psychosocial treatment, schizophrenia",
author = "Hilary Mairs and Karina Lovell and Malcolm Campbell and Philip Keeley",
year = "2011",
month = "9",
day = "1",
doi = "10.1177/0145445511411706",
language = "English",
volume = "35",
pages = "486--506",
journal = "Behavior Modification",
issn = "0145-4455",
publisher = "SAGE Publications Inc.",
number = "5",

}

Development and pilot investigation of behavioral activation for negative symptoms. / Mairs, Hilary; Lovell, Karina; Campbell, Malcolm; Keeley, Philip.

In: Behavior Modification, Vol. 35, No. 5, 01.09.2011, p. 486-506.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Development and pilot investigation of behavioral activation for negative symptoms

AU - Mairs, Hilary

AU - Lovell, Karina

AU - Campbell, Malcolm

AU - Keeley, Philip

PY - 2011/9/1

Y1 - 2011/9/1

N2 - Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment.

AB - Negative symptoms cause functional impairment and impede recovery from psychosis, not least, because of limited developments in empirically validated treatments. This article details a pilot evaluation of a behavioral activation (BA) treatment with eight people presenting with psychosis and marked negative symptoms. The rationale for this development was that BA is effective in treating depression, a condition that shares overlapping features with negative symptoms. Results provide preliminary support for feasibility and effectiveness of BA for negative symptoms in terms of treatment adherence, retention, and initial outcomes. However, additional advantages may accrue from revisions to the BA treatment.

KW - negative symptoms

KW - psychosis

KW - psychosocial treatment

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=79960979208&partnerID=8YFLogxK

U2 - 10.1177/0145445511411706

DO - 10.1177/0145445511411706

M3 - Article

VL - 35

SP - 486

EP - 506

JO - Behavior Modification

JF - Behavior Modification

SN - 0145-4455

IS - 5

ER -